GSK-202062

Study Sponsor: GSK

Study Title

A single-centre, double-blind (sponsor open), placebo controlled two part study to evaluate the safety, tolerability and pharmacokinetics of single and repeat doses of GSK2292767 as a dry powder in healthy participants who smoke cigarettes

Medicine or Vaccine (generic name)

GSK2292767

Sponsor Identification Number

202062

Trial Registry Identification Number(#'s)

NCT03045887 2016-003188-21

Medical Condition

Asthma

Phase

Phase 1

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=202062

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT03045887

Link to study details on EudraCT (if available)

https://www.clinicaltrialsregister.eu/ctr-search/search?query=/2016-003188-21

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

An annotated case report form is not available for this study. A blank case report form will be provided.

Date Added to this Site

May 2019